Citius Pharmaceuticals, Inc. (CTXR)
Nasdaq: CTXR · Pharmaceutical Preparations · Cranford, NJ · filing with the SEC since 2010
Who owns Citius Pharmaceuticals, Inc.
As filed with the SECHolders of 5% or more
1
CVI Investments, Inc. holds 9.9% of Common Stock, $0.001 par value per share, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
2
report now, of 11 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
CVI Investments, Inc.
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.001 par value per share · 9.9% in Feb 17, 2026
What CTXR reports owning in othersstakes of 5% or more, and other ties
Citius Oncology, Inc. CTOR
SCHEDULE 13D/A · filed Jun 4, 2026 · Common Shares, $0.0001 par value per share
Other ties the annual report names
Citius Pharma
An entity · consolidated entity · owns, named in the 10-K filed Dec 23, 2025
Nove Cite
An investee · investee · invested in, named in the 10-K filed Dec 23, 2025
4 subsidiaries in 1 country, from the list filed with the 10-K filed Dec 29, 2023.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2019 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.